Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.

Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...

The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as a first-line therapy for patients with a ...

Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has been agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...

Minister for Social Security and Disabilities, Sir Stephen Timms also reassured existing PIP claimants with an outstanding ...

The agency changed course just days after firing employees who oversee the safety of food and life-sustaining medical devices ...

RBI raises loan limits for urban cooperative banks, adjusts real estate exposure norms, and extends deadline for prudential ...

Neuren Pharmaceuticals was among the best-performing ASX 200 stocks in morning trade after securing a rare pediatric disease ...

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida ...

A decision has yet to be made by the Bermuda Tourism Authority on whether access to information about spending on any ...

Crab cakes are a pretty popular menu item at restaurants. These are the best and worst chain restaurant crab cakes, ranked ...